A study of incidence of respiratory distress syndrome in newborns born to mothers with gestational diabetes


  • Rajith M. L. Department of Pediatrics, Sri Siddhartha Medical College, Agalakote, Tumkur, Karnataka, India
  • Punyashree R. Department of Obstetrics and Gynecology, Siddaganga Medical College and Research Institute, Tumkur, Karnataka, India




Hyaline membrane disease, Surfactant protein, Surfactant lipids, Infants of a diabetic mother, RDS, Lung development, Hyperglycemia


Background: Hyaline membrane disease/RDS is an important cause for newborn morbidity and mortality. Many studies have established an association of infants of diabetic mothers (IDMs) with respiratory distress syndrome (RDS) since decades. Modern lifestyle changes have increased the prevalence of obesity in women and thus diabetes in pregnancy. Maintaining strict euglycemia is a double-edged sword in pregnancy which has been affecting the neonatal health and respiratory maturity in particular which has been associated with increased mortality and morbidity.

Methods: It was a prospective case control study done over a span of one year.

Results: Hyaline membrane disease (RDS) is significantly associated with gestational diabetes mellitus (GDM).

Conclusions: Even our study emphasized the ill effects of gestational diabetes on the respiratory development of baby. Most of the babies are manageable and outcome can be drastically improved by early diagnosis and efficient treatment. Education and anticipation of the complications and prompt referral are the need of the hour in peripheries and advancement of neonatal intensive cares in the referral hospitals is needed.


Dabelea D, Snell-Bergeon JK, Hartsfield CL, Bischoff KJ, Hamman RF, McDuffie RS. Increasing prevalence of gestational diabetes mellitus (GDM) over time and by birth cohort: Kaiser Permanente of Colorado GDM screening program. Diabetes Care. 2005;28(3):579-84.

Mackin ST, Nelson SM, Kerssens JJ, Wood R, Wild S, Colhoun HM, et al. Diabetes and pregnancy: National trends over a 15 year period. Diabetologia. 2018;61(5):1081-8.

International Diabetes Federation. IDF Diabetes Atlas, 9th ed.; Atlas De La Diabetes De La Fid: Brussels, Belgium, 2019.

Barbour LA, McCurdy CE, Hernandez TL, Kirwan JP, Catalano PM, Friedman JE. Cellular mechanisms for insulin resistance in normal pregnancy and gestational diabetes. Diabetes Care. 2007;30(2):S112-9.

Sonagra AD. Normal Pregnancy-A State of Insulin Resistance. J Clin Diagn Res. 2014;8(11):CC01-3.

Kitzmiller JL, Block JM, Brown FM, Catalano PM, Conway DL, Coustan DR, et al. Managing preexisting diabetes for pregnancy: Summary of evidence and consensus recommendations for care. Diabetes Care. 2008;31(5):1060-79.

Chen CP. Congenital malformations associated with maternal diabetes. Taiwan. J Obs Gynecol. 2005;44:1-7.

Becerra JE, Khoury MJ, Cordero JF, Erickson JD. Diabetes mellitus during pregnancy and the risks for specific birth defects: A population-based case-control study. Pediatrics. 1990;85(1):1-9.

Avery ME, Mead J. Surface Properties in Relation to Atelectasis and Hyaline Membrane Disease. Am J Dis Child. 1959;97(5pt1):517-23.

Gellis SS, Hsia DY. The infant of diabetic mother. Am J Dis Child. 1959;97(1):1-41.

Kawakita T, Bowers K, Hazrati S, Zhang C, Grewal J, Chen Z, et al. Increased Neonatal Respiratory Morbidity Associated with Gestational and Pregestational Diabetes: a retrospective study. Am J Perinatol. 2017;34(11):1160-8.

Bental Y, Reichman B, Shiff Y, Meir W, Valentina B, Liat LG, et al. Impact of maternal diabetes mellitus on mortality and morbidity of preterm infants (24-33 weeks’ gestation). Pediatrics. 2011;128(4):e848-55.

Mallah KO, Nirchi H, Kulaylat NA, Shaban MS. Gestational and pre-gestational diabetes: compareson of maternal and fetal characteristics and outcome. Int J Gynaecol Obstet 1997;58(2):203-9.

Becquet O, El Khabbaz F, Alberti C, Damir M, Audrey B, Valérie B, et al. Insulin treatment of maternal diabetes mellitus and respiratory outcome in latepreterm and term singletons. BMJ Open. 2015;5:e008192.

Mimouni F, Miodovnik M, Whitsett JA, Holroyde JC, Siddiqi TA, Tsang RC. Respiratory distress syndrome in infants of diabetic mothers in the 1980s: no direct adverse effect of maternal diabetes with modern management. Obstet Gynecol. 1987;69(2):191-5.

McMahan MJ, Mimouni F, Miodovnik M. Surfactant associated protein (SAP-35) in amniotic fluid from diabetic and nondiabetic pregnancies. Obstet Gynecol. 1987;70(1):94-8.

McGillick EV, Morrison JL, McMillen IC, Orgeig S. Intrafetal glucose infusion alters glucocorticoid signalling and reduces surfactant protein mRNA expression in the lung of the late gestation sheep fetus. Am J Physiol Regul Integr Comp Physiol. 2014;307(5):R538-45.

Robert MF, Neff RK, Hubbell JP, Taeusch HW, Avery ME. Association between Maternal Diabetes and the Respiratory-Distress Syndrome in the Newborn. N Engl J Med. 1976;294:357-60.

Matti P, Pistoia L, Fornalè M, Brunn E, Zardini E. Prevalence of RDS in diabetic pregnancy. Minerva Ginecol. 1996;48(10):409-13.

Mortier I, Blanc J, Tosello B, Gire C, Bretelle F, Carcopino X. Is gestational diabetes an independent risk factor of neonatal severe respiratory distress syndrome after 34 weeks of gestation? A prospective study. Arch Gynecol Obstet. 2017;296(6):1071-77.

Li Y, Wang W, Zhang D. Maternal diabetes mellitus and risk of neonatal respiratory distress syndrome: a meta-analysis. Acta Diabetologica. 2019;56(7):729-40.






Original Research Articles